PALSONIFY
NDC 84015-930, PALTUSOTINE, tablet, film coated, from Crinetics Pharmaceuticals, Inc..
- Product NDC
- 84015-930
- Status
- Listed
- Labeler
- Crinetics Pharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219070
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/84015-930 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PALTUSOTINE HYDROCHLORIDE30 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 84015-930-60 | 84015093060 | 60 TABLET, FILM COATED in 1 BOTTLE (84015-930-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8a6d2ce0-a621-4ee7-983c-977cd948ff4d
Use it
Look up 84015-930 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/84015-930 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 84015-930. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.